HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$1.13
Day range
$1.10 - $1.28
Year range
$0.85 - $4.40
Market cap
34.80M USD
Avg Volume
23.86K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.30M | -15.62% |
Net income | -3.77M | 8.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.29M | 15.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.60M | -32.41% |
Total assets | 50.56M | 1,061.01% |
Total liabilities | 28.33M | 518.08% |
Total equity | 22.23M | — |
Shares outstanding | 28.88M | — |
Price to book | 1.35 | — |
Return on assets | -40.29% | — |
Return on capital | -108.49% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.77M | 8.84% |
Cash from operations | -2.12M | 51.83% |
Cash from investing | 382.00K | — |
Cash from financing | 2.15M | -38.75% |
Net change in cash | 413.00K | 146.61% |
Free cash flow | 6.85M | — |
About
Founded
2004
Headquarters
Website
Employees
7
